Annals of Surgical Oncology Sign the Guestbook
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
10.1245/s10434-007-9789-6
Annals of Surgical Oncology 15:1211-1217 (2008)
© 2008 Society of Surgical Oncology
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Erickson, J. L.
Right arrow Articles by Hieken, T. J.
PubMed
Right arrow Articles by Erickson, J. L.
Right arrow Articles by Hieken, T. J.

Original Article

Compliance with Melanoma Treatment Guidelines in a Community Teaching Hospital: Time Trends and Other Variables

Jennifer L. Erickson, MD1,2, Josè M. Velasco, MD1,2 and Tina J. Hieken, MD1,2

1 Department of Surgery, Rush North Shore Medical Center, 9669 North Kenton, Suite 204, Skokie, Illinois 60076, USA
2 Department of General Surgery, Rush University Medical Center and Rush Medical College, Chicago, Illinois, USA

Correspondence: Address correspondence and reprint requests to: Tina J. Hieken, MD; E-mail: thieken{at}rush.edu

Background: Variation in the surgical treatment of melanoma occurs despite efforts to standardize care. This may lead to morbidity, inaccurate staging, and poor outcomes, or it may be cost ineffective. The purpose of our study was to evaluate our institutional compliance with National Comprehensive Cancer Network (NCCN) melanoma treatment guidelines.

Methods: We studied 252 clinically node-negative melanoma patients identified from our cancer registry. Treatment data were confirmed by individual review of pathology and operative reports.

Results: Documented margins of excision conformed to NCCN guidelines in 87% of Tis–T1 tumors and 60% of T2–T4 tumors. Lymph node staging was performed in 11% of T1a, 64% of T1b, 74% of T2, 63% of T3, and 47% of T4 patients. Treatment by a surgical oncologist achieved margin and lymph node compliance in 95% and 92% of cases versus other practitioners in 38% and 67%, respectively (P < .0001). Documented compliance with margin guidelines improved from 46% to 73% for the years 1995 to 1999 versus 2000 to 2004 (P < .0001) and for lymph node staging and treatment from 74% to 84% (P = .04). Other factors associated with greater adherence to NCCN guidelines were patient age <80 years, upper extremity tumors, and thinner tumors (all P < .05).

Conclusions: Our data suggest that our compliance with NCCN melanoma treatment guidelines was suboptimal. Treatment directed by a surgical oncologist showed the highest rate of adherence to national standards. Further investigation is needed to determine the effect of this on patient outcomes and how best to provide high-quality care to the greatest number of melanoma patients.

Key Words: Melanoma • Surgical treatment • Guideline compliance • Excision margins • Sentinel lymph node biopsy






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the Society of Surgical Oncology.